Alignment Healthcare, Inc. (NASDAQ:ALHC) Receives Average Rating of “Moderate Buy” from Analysts

Alignment Healthcare, Inc. (NASDAQ:ALHC) has earned an average rating of “Moderate Buy” from the twelve analysts that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $24.5556.

Several equities research analysts have recently commented on ALHC shares. UBS Group boosted their target price on shares of Alignment Healthcare from $18.00 to $21.00 and gave the company a “neutral” rating in a research note on Wednesday, January 14th. KeyCorp reissued an “overweight” rating and set a $28.00 price target on shares of Alignment Healthcare in a report on Thursday, January 22nd. JPMorgan Chase & Co. boosted their price target on shares of Alignment Healthcare from $23.00 to $26.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Robert W. Baird set a $28.00 price objective on shares of Alignment Healthcare in a research note on Friday, January 30th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Alignment Healthcare in a report on Wednesday, January 21st.

Insider Buying and Selling at Alignment Healthcare

In other Alignment Healthcare news, insider Andreas P. Wagner sold 21,118 shares of the business’s stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $18.62, for a total value of $393,217.16. Following the transaction, the insider owned 148,687 shares of the company’s stock, valued at approximately $2,768,551.94. The trade was a 12.44% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Hyong Kim sold 16,506 shares of the stock in a transaction on Tuesday, January 6th. The stock was sold at an average price of $21.35, for a total value of $352,403.10. Following the sale, the insider owned 333,133 shares in the company, valued at $7,112,389.55. The trade was a 4.72% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 2,147,056 shares of company stock worth $42,192,787 over the last 90 days. Company insiders own 7.00% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. T. Rowe Price Investment Management Inc. lifted its position in Alignment Healthcare by 0.6% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 12,643,784 shares of the company’s stock worth $249,715,000 after buying an additional 79,268 shares in the last quarter. Invesco Ltd. increased its position in Alignment Healthcare by 38.9% in the 4th quarter. Invesco Ltd. now owns 6,202,592 shares of the company’s stock valued at $122,501,000 after acquiring an additional 1,735,962 shares in the last quarter. Mercer Global Advisors Inc. ADV increased its position in Alignment Healthcare by 6.9% in the 4th quarter. Mercer Global Advisors Inc. ADV now owns 15,452 shares of the company’s stock valued at $305,000 after acquiring an additional 996 shares in the last quarter. Mackenzie Financial Corp raised its stake in shares of Alignment Healthcare by 25.6% in the fourth quarter. Mackenzie Financial Corp now owns 46,917 shares of the company’s stock worth $901,000 after acquiring an additional 9,552 shares during the last quarter. Finally, nVerses Capital LLC bought a new position in shares of Alignment Healthcare in the fourth quarter worth about $396,000. 86.19% of the stock is owned by institutional investors.

Alignment Healthcare Price Performance

Shares of Alignment Healthcare stock traded down $0.13 during midday trading on Friday, hitting $18.44. 5,528,018 shares of the company were exchanged, compared to its average volume of 2,768,860. The company has a debt-to-equity ratio of 1.80, a current ratio of 1.71 and a quick ratio of 1.61. The firm has a market cap of $3.77 billion, a P/E ratio of -1,842.16, a PEG ratio of 2.72 and a beta of 1.18. Alignment Healthcare has a 52 week low of $11.63 and a 52 week high of $23.87. The firm has a 50 day simple moving average of $20.95 and a 200-day simple moving average of $18.65.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings results on Thursday, February 26th. The company reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.10. Alignment Healthcare had a negative return on equity of 0.49% and a negative net margin of 0.02%.The firm had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $1 billion. During the same period in the prior year, the business posted ($0.16) earnings per share. The business’s revenue was up 44.4% compared to the same quarter last year. Research analysts forecast that Alignment Healthcare will post -0.69 earnings per share for the current year.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.